Patents Assigned to Lakewood-Amedex, Inc.
-
Patent number: 11795192Abstract: Antimicrobial compounds and compositions of Formulas (V), (VI), (VII), (VIII), and (IX), and methods of use are disclosed.Type: GrantFiled: August 17, 2022Date of Patent: October 24, 2023Assignee: Lakewood Amedex, Inc.Inventors: Steven A. Kates, Randolph B. Sleet, Steven Parkinson
-
Patent number: 11377468Abstract: A method of treating an infection of at least one of a wound or a ulcer in a patient in need thereof according to an embodiment includes administering to the patient an effective amount of a compound having the formula: or a pharmaceutically acceptable salt thereof.Type: GrantFiled: April 19, 2021Date of Patent: July 5, 2022Assignee: Lakewood Amedex, Inc.Inventors: Randolph B. Sleet, Steven A. Kates, Steven Parkinson
-
Patent number: 11123357Abstract: Methods and pharmaceutical compositions including Bisphosphocins for treating oral mucositis in a patient are disclosed.Type: GrantFiled: October 17, 2019Date of Patent: September 21, 2021Assignee: Lakewood Amedex, Inc.Inventors: Steven A. Kates, Steven Parkinson, Patrick C. O'Connor
-
Patent number: 11096954Abstract: Gel formulations including a Bisphosphocin having antimicrobial activity are disclosed. Methods of using the gel formulations including a Bisphosphocin are further disclosed.Type: GrantFiled: June 12, 2018Date of Patent: August 24, 2021Assignee: Lakewood Amedex, Inc.Inventors: Steven A. Kates, Keith Arthur Johnson
-
Patent number: 10981943Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.Type: GrantFiled: July 29, 2020Date of Patent: April 20, 2021Assignee: Lakewood Amedex, Inc.Inventors: Randolph B. Sleet, Steven A. Kates, Steven Parkinson
-
Patent number: 10752651Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.Type: GrantFiled: July 8, 2019Date of Patent: August 25, 2020Assignee: Lakewood Amedex, Inc.Inventors: Randolph B. Sleet, Steven A. Kates, Steven Parkinson
-
Patent number: 10711028Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.Type: GrantFiled: July 8, 2019Date of Patent: July 14, 2020Assignee: Lakewood Amedex, Inc.Inventors: Randolph B. Sleet, Steven A. Kates, Steven Parkinson
-
Patent number: 10378014Abstract: The invention provides compositions of oligonucleotides targeted at influenza genes and at host animal genes involved in response to influenza infection. In some embodiments, the oligonucleotides are modified. In some embodiments, the compositions contain one, or more than one, oligonucleotide. The invention also provides methods and kits using the compositions of the invention for the treatment and prevention of influenza.Type: GrantFiled: January 6, 2017Date of Patent: August 13, 2019Assignee: Lakewood Amedex, Inc.Inventors: Roderic M.K. Dale, Lun-Quan Sun
-
Patent number: 9574243Abstract: The invention provides compositions of oligonucleotides targeted at influenza genes and at host animal genes involved in response to influenza infection. In some embodiments, the oligonucleotides are modified. In some embodiments, the compositions contain one, or more than one, oligonucleotide. The invention also provides methods and kits using the compositions of the invention for the treatment and prevention of influenza.Type: GrantFiled: July 18, 2006Date of Patent: February 21, 2017Assignee: Lakewood Amedex, Inc.Inventors: Roderic M. K. Dale, Lun-Quan Sun
-
Patent number: 9567584Abstract: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.Type: GrantFiled: November 6, 2014Date of Patent: February 14, 2017Assignee: Lakewood Amedex, Inc.Inventors: Roderic M.K. Dale, Amy Arrow, Teresa Thompson
-
Patent number: 8916529Abstract: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.Type: GrantFiled: February 9, 2007Date of Patent: December 23, 2014Assignee: Lakewood-Amedex, Inc.Inventors: Roderic M. K. Dale, Amy Arrow, Terry Thompson
-
Patent number: 8435960Abstract: The present invention provides devices and compositions for the management of infection of topical lesions, each of the devices and compositions containing protonated/acidified nucleic acids either on its surface, or integrated into the device. These modified nucleic acids are effective as bactericidal and/or bacteriostatic agents without regard to the class of bacteria, so are especially useful when diagnosis is difficult or when multiple infectious organisms are present. The antibiotic activity of nucleic acids of the invention is not dependent on either the specific sequence of the nucleic acid or the length of the nucleic acid molecule. The nucleic acids used in the invention are protonated/acidified to give a pH when dissolved in water of less than pH 7 to about 1, more preferably less than pH 4.5 to about 1, and even more preferably less than pH 2 to about 1.Type: GrantFiled: May 30, 2008Date of Patent: May 7, 2013Assignee: Lakewood-Amedex, Inc.Inventors: Roderic M. K. Dale, Steven L. Gatton, Amy Arrow
-
Patent number: 8188259Abstract: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.Type: GrantFiled: February 9, 2007Date of Patent: May 29, 2012Assignee: Lakewood-Amedex, Inc.Inventors: Roderic M. K. Dale, Amy Arrow, Terry Thompson
-
Patent number: 8183361Abstract: The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.Type: GrantFiled: February 9, 2007Date of Patent: May 22, 2012Assignee: Lakewood-Amedex, Inc.Inventors: Roderic M. K. Dale, Amy Arrow, Terry Thompson
-
Patent number: 8097596Abstract: The invention provides compositions of oligonucleotides targeted at genes involved in muscle wasting and/or muscle growth. In some embodiments, the oligonucleotides are modified. In some embodiments, the compositions contain one, or more than one, oligonucleotide. The invention also provides methods and kits using the compositions of the invention for the treatment of muscle wasting conditions and/or the promotion of muscle growth.Type: GrantFiled: June 30, 2006Date of Patent: January 17, 2012Assignee: Lakewood-Amedex, Inc.Inventor: Roderic M. K. Dale
-
Publication number: 20110135713Abstract: The present invention provides protonated compounds having antiviral and antimicrobial activity. The invention also provides antimicrobial compositions comprising protonated compounds of the invention. The protonated compounds of the invention provide efficacious antimicrobial activity against resistant strains of bacteria and opportunistic fungi. The invention also provides antiviral compositions comprising compounds of the invention. Viruses that may be treated by compositions of the invention include, but are not limited to, HIV, HSV, CMV, HBV, HCV and influenza virus.Type: ApplicationFiled: January 6, 2011Publication date: June 9, 2011Applicant: Lakewood-Amedex, Inc.Inventor: Roderic M.K. Dale
-
Patent number: 7868162Abstract: The present invention provides protonated compounds having antiviral and antimicrobial activity. The invention also provides antimicrobial compositions comprising protonated compounds of the invention. The protonated compounds of the invention provide efficacious antimicrobial activity against resistant strains of bacteria and opportunistic fungi. The invention also provides antiviral compositions comprising compounds of the invention. Viruses that may be treated by compositions of the invention include, but are not limited to, HIV, HSV, CMV, HBV, HCV and influenza virus.Type: GrantFiled: October 25, 2006Date of Patent: January 11, 2011Assignee: Lakewood-Amedex, Inc.Inventor: Roderic M. K. Dale